GNG7 is frequently downregulated in various cancers including pancreatic cancer, esophageal cancer and clear cell renal cell carcinoma (Shibata et al., 1998; Ohta et al., 2008; Xu et al., 2019). Here, GNG7 is linked to familial pancreatic carcinoma.